FSHPR Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
-
Past Year
-
Growth Past 5yrs
N/A
Next Quarter
-
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On N/A
Actual EPS vs Estimated EPS
There are no recent earnings per share (EPS) results available for FSHPR.
Earnings History
No earnings history is available at this time.
Frequently Asked Questions
Is FSHPR stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given FSHPR stock an average recommendation of
N/A. 0 analysts have given their ratings
to FSHPR out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for FSHPR highest price target?
Analysts suggest FSHPR's stock price would rise to a high of -.
What is the lowest price target analysts expect for FSHPR over the next year?
Within the next 12 months, analysts predict the FSHPR stock price could move to -.
What is the average target price for FSHPR?
FSHPR stock has an average analyst estimate of -.
At its current price, how far is FSHPR from its average target price?
FSHPR shares are currently trading 0% below this price target.
What were FSHPR’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - versus consensus estimates of -, and null the comparable year-ago quarter’s EPS of -.
What are the current estimates for quarterly and annual earnings per share?
FSHPR's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
What has FSHPR's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for FSHPR in the next five years, compared to growth rates of N/A in the past five years.